(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202309 | 202209 | % Var | 202309 | 202209 | % Var | 202303 | 202203 | % Var | |
| Sales | 36592.30 | 28289.60 | 29.35 | 71548.70 | 55614.50 | 28.65 | 112588.30 | 117716.70 | -4.36 |
| Other Income | 256.00 | 153.70 | 66.56 | 533.40 | 218.50 | 144.12 | 912.60 | 1504.20 | -39.33 |
| PBIDT | 8608.40 | 3290.30 | 161.63 | 15936.00 | 6242.10 | 155.30 | 11739.20 | 4261.30 | 175.48 |
| Interest | 153.20 | 183.80 | -16.65 | 315.00 | 382.50 | -17.65 | 984.40 | 734.70 | 33.99 |
| PBDT | 8455.20 | 3106.50 | 172.18 | 15621.00 | 5859.60 | 166.59 | 10754.80 | 3526.60 | 204.96 |
| Depreciation | 1494.80 | 1377.60 | 8.51 | 2895.30 | 2681.10 | 7.99 | 5483.40 | 5141.90 | 6.64 |
| PBT | 6960.40 | 1728.90 | 302.59 | 12725.70 | 3178.50 | 300.37 | 5271.40 | -1615.30 | -426.34 |
| TAX | 1474.30 | 242.70 | 507.46 | 2470.00 | 520.50 | 374.54 | 1019.30 | 271.70 | 275.16 |
| Deferred Tax | 177.70 | -45.00 | -494.89 | 166.20 | -56.60 | -393.64 | 60.40 | -306.30 | -119.72 |
| PAT | 5486.10 | 1486.20 | 269.14 | 10255.70 | 2658.00 | 285.84 | 4252.10 | -1887.00 | -325.34 |
| Equity | 910.50 | 909.40 | 0.12 | 910.50 | 909.40 | 0.12 | 910.00 | 909.00 | 0.11 |
| PBIDTM(%) | 23.53 | 11.63 | 102.27 | 22.27 | 11.22 | 98.44 | 10.43 | 3.62 | 188.03 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1869.50 |
| Dr. Reddys Labs. | 1337.40 |
| Cipla | 1457.50 |
| Zydus Lifesciences | 1108.85 |
| Lupin | 2396.20 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: